Yablonka Uri 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Yablonka Uri
DirectorChief Operating Officer
Transactions
- Award
Common Stock
2025-01-01+20,000→ 68,464 total - Award
Common Stock
2025-01-01+40,000→ 48,464 total
Footnotes (3)
- [F1]Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan (the "Plan"). The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
- [F2]Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.
- [F3]Represents shares of restricted stock units ("RSUs") awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.